181 related articles for article (PubMed ID: 31771862)
1. Strengthening national teams of experts to support HPV vaccine introduction in Eastern Mediterranean countries: Lessons learnt and recommendations from an international workshop.
Dochez C; Al Awaidy S; Mohsni E; Fahmy K; Bouskraoui M
Vaccine; 2020 Jan; 38(5):1114-1119. PubMed ID: 31771862
[TBL] [Abstract][Full Text] [Related]
2. Lessons learnt during the national introduction of human papillomavirus (HPV) vaccination programmes in 6 African countries: Stakeholders' perspectives.
Abdullahi LH; Hussey GD; Wiysonge CS; Kagina BM
S Afr Med J; 2020 May; 110(6):525-531. PubMed ID: 32880566
[TBL] [Abstract][Full Text] [Related]
3. Introduction of human papillomavirus (HPV) vaccination into national immunisation schedules in Europe: Results of the VENICE 2007 survey.
King LA; Lévy-Bruhl D; O'Flanagan D; Bacci S; Lopalco PL; Kudjawu Y; Salmaso S;
Euro Surveill; 2008 Aug; 13(33):. PubMed ID: 18761891
[TBL] [Abstract][Full Text] [Related]
4. Improving skills and institutional capacity to strengthen adolescent immunisation programmes and health systems in African countries through HPV vaccine introduction.
Dochez C; Burnett RJ; Mbassi SM; Were F; Musyoki A; Trovoada D; Mphahlele MJ
Papillomavirus Res; 2017 Dec; 4():66-71. PubMed ID: 29179872
[TBL] [Abstract][Full Text] [Related]
5. Human papillomavirus vaccine introduction--the first five years.
Markowitz LE; Tsu V; Deeks SL; Cubie H; Wang SA; Vicari AS; Brotherton JM
Vaccine; 2012 Nov; 30 Suppl 5():F139-48. PubMed ID: 23199957
[TBL] [Abstract][Full Text] [Related]
6. Prospects and challenges in the introduction of human papillomavirus vaccines in the extended Middle East and North Africa region.
Jumaan AO; Ghanem S; Taher J; Braikat M; Al Awaidy S; Dbaibo GS
Vaccine; 2013 Dec; 31 Suppl 6():G58-64. PubMed ID: 24331821
[TBL] [Abstract][Full Text] [Related]
7. Human papillomavirus (HPV) vaccination: from clinical studies to immunization programs.
Murillo R; Ordóñez-Reyes C
Int J Gynecol Cancer; 2019 Oct; 29(8):1317-1326. PubMed ID: 31455660
[TBL] [Abstract][Full Text] [Related]
8. The current state of introduction of HPV vaccination into national immunisation schedules in Europe: results of the VENICE 2008 survey.
Lévy-Bruhl D; Bousquet V; King LA; O'Flanagan D; Bacci S; Lopalco PL; Salmaso S;
Eur J Cancer; 2009 Oct; 45(15):2709-13. PubMed ID: 19695863
[TBL] [Abstract][Full Text] [Related]
9. Supporting countries in establishing and strengthening NITAGs: lessons learned from 5 years of the SIVAC initiative.
Adjagba A; Senouci K; Biellik R; Batmunkh N; Faye PC; Durupt A; Gessner BD; da Silva A
Vaccine; 2015 Jan; 33(5):588-95. PubMed ID: 25545597
[TBL] [Abstract][Full Text] [Related]
10. What works for human papillomavirus vaccine introduction in low and middle-income countries?
Howard N; Gallagher KE; Mounier-Jack S; Burchett HED; Kabakama S; LaMontagne DS; Watson-Jones D
Papillomavirus Res; 2017 Dec; 4():22-25. PubMed ID: 29179865
[TBL] [Abstract][Full Text] [Related]
11. The current state of introduction of human papillomavirus vaccination into national immunisation schedules in Europe: first results of the VENICE2 2010 survey.
Dorleans F; Giambi C; Dematte L; Cotter S; Stefanoff P; Mereckiene J; O'Flanagan D; Lopalco PL; D'Ancona F; Levy-Bruhl D;
Euro Surveill; 2010 Nov; 15(47):. PubMed ID: 21144444
[TBL] [Abstract][Full Text] [Related]
12. Human papillomavirus (HPV) vaccine coverage achievements in low and middle-income countries 2007-2016.
Gallagher KE; Howard N; Kabakama S; Mounier-Jack S; Burchett HED; LaMontagne DS; Watson-Jones D
Papillomavirus Res; 2017 Dec; 4():72-78. PubMed ID: 29179873
[TBL] [Abstract][Full Text] [Related]
13. Cost-effectiveness analysis of the introduction of the human papillomavirus vaccine in Honduras.
Aguilar IB; Mendoza LO; García O; Díaz I; Figueroa J; Duarte RM; Perdomo G; Garcia AG; Janusz CB
Vaccine; 2015 May; 33 Suppl 1():A167-73. PubMed ID: 25919157
[TBL] [Abstract][Full Text] [Related]
14. A Meta-Analysis on Human Papillomavirus Type Distribution among Women with Cervical Neoplasia in the WHO Eastern Mediterranean Region.
Shoja Z; Farahmand M; Hosseini N; Jalilvand S
Intervirology; 2019; 62(3-4):101-111. PubMed ID: 31527382
[TBL] [Abstract][Full Text] [Related]
15. Supporting national immunization technical advisory groups (NITAGs) in resource-constrained settings. New strategies and lessons learned from the Task Force for Global Health's Partnership for influenza vaccine introduction.
Ba-Nguz A; Shah A; Bresee JS; Lafond KE; Cavallaro K; Shefer A; Donadel M; Seward JF
Vaccine; 2019 Jun; 37(28):3646-3653. PubMed ID: 31130258
[TBL] [Abstract][Full Text] [Related]
16. Country recommendations on the inclusion of HPV vaccines in national immunization programmes among high-income countries, June 2006-January 2008.
Koulova A; Tsui J; Irwin K; Van Damme P; Biellik R; Aguado MT
Vaccine; 2008 Dec; 26(51):6529-41. PubMed ID: 18805453
[TBL] [Abstract][Full Text] [Related]
17. Global implementation of human papillomavirus (HPV) vaccine: lessons from hepatitis B vaccine.
Kane MA
Gynecol Oncol; 2010 May; 117(2 Suppl):S32-5. PubMed ID: 20129654
[TBL] [Abstract][Full Text] [Related]
18. Implementation of a national school-based Human Papillomavirus (HPV) vaccine campaign in Fiji: knowledge, vaccine acceptability and information needs of parents.
La Vincente SF; Mielnik D; Jenkins K; Bingwor F; Volavola L; Marshall H; Druavesi P; Russell FM; Lokuge K; Mulholland EK
BMC Public Health; 2015 Dec; 15():1257. PubMed ID: 26684658
[TBL] [Abstract][Full Text] [Related]
19. Human papillomavirus (HPV) vaccine implementation in low and middle-income countries (LMICs): health system experiences and prospects.
Wigle J; Coast E; Watson-Jones D
Vaccine; 2013 Aug; 31(37):3811-7. PubMed ID: 23777956
[TBL] [Abstract][Full Text] [Related]
20. Vaccine programme stakeholder perspectives on a hypothetical single-dose human papillomavirus (HPV) vaccine schedule in low and middle-income countries.
Gallagher KE; Kelly H; Cocks N; Dixon S; Mounier-Jack S; Howard N; Watson-Jones D
Papillomavirus Res; 2018 Dec; 6():33-40. PubMed ID: 30352297
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
